Targeting Mouse Double Minute 2: Current Concepts in DNA Damage Repair and Therapeutic Approaches in Cancer
Open Access
- 7 May 2020
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 11, 631
Abstract
Defects in DNA damage repair may cause genome instability and cancer development. The tumor suppressor gene p53 regulates cell cycle arrest to allow time for DNA repair. The oncoprotein mouse double minute 2 (MDM2) promotes cell survival, proliferation, invasion, and therapeutic resistance in many types of cancer. The major role of MDM2 is to inhibit p53 activity and promote its degradation. In this review, we describe the influence of MDM2 on genomic instability, the role of MDM2 on releasing p53 and binding DNA repair proteins to inhibit repair, and the regulation network of MDM2 including its transcriptional modifications, protein stability, and localization following DNA damage in genome integrity maintenance and in MDM2-p53 axis control. We also discuss p53-dependent and p53 independent oncogenic function of MDM2 and the outcomes of clinical trials that have been used with clinical inhibitors targeting p53-MDM2 to treat certain cancers.Keywords
Funding Information
- National Natural Science Foundation of China
- National Natural Science Foundation of China
This publication has 204 references indexed in Scilit:
- The DNA Damage Response: Making It Safe to Play with KnivesMolecular Cell, 2010
- RETRACTED: Downregulation of p53-inducible microRNAs 192, 194, and 215 Impairs the p53/MDM2 Autoregulatory Loop in Multiple Myeloma DevelopmentCancer Cell, 2010
- Privileged scaffolds for library design and drug discoveryCurrent Opinion in Chemical Biology, 2010
- ATM activates p53 by regulating MDM2 oligomerization and E3 processivityThe EMBO Journal, 2009
- Acetylation Is Indispensable for p53 ActivationCell, 2008
- High levels of the p53 inhibitor MDM4 in head and neck squamous carcinomasHuman Pathology, 2007
- Chromatin Modifications and Their FunctionCell, 2007
- Regulation of p53 stability by Mdm2Nature, 1997
- Mdm2 promotes the rapid degradation of p53Nature, 1997
- Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53Nature, 1993